Floatz logo

Therapeutic Asset Ratings

153 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
[18F]MODAG-009
Parkinson Disease
MODAG GmbHEarly P1C (34)
NOS
Parkinson Disease
University of PennsylvaniaEarly P1C (34)
Yohimbine
Parkinson Disease
Hospices Civils de LyonEarly P1C (34)
(2S)-1-FLUORO-3-((2-(6-METHYL-3-PYRIDYL)-6-QUINOLYL)OXY)PROPAN-2-OL
Parkinson Disease
Anhui Provincial HospitalD (28)
AMMONIA N-13
Parkinson Disease
National Institute of Neurological Disorders and Stroke (NINDS)D (28)
APIGENINE
Parkinson Disease
Jinnah Postgraduate Medical CentreN/AD (28)
Carboplatin
Parkinson Disease
University of Colorado, DenverN/AD (28)
CARFENTANYL
Parkinson Disease
Hospices Civils de LyonN/AD (28)
Chamomile
Parkinson Disease
Jinnah Postgraduate Medical CentreN/AD (28)
CIMBI-36
Parkinson Disease
University of ExeterD (28)
CLOSTRIDIUM BUTYRICUM MIYAIRI 588
Parkinson Disease
Kaohsiung Medical University Chung-Ho Memorial HospitalN/AD (28)
Cobalamin
Parkinson Disease
Babujinaya CelaN/AD (28)
Cyclophosphamide
Parkinson Disease
Oregon Health and Science UniversityN/AD (28)
DASB
Parkinson Disease
University of ExeterD (28)
Epirubicin
Parkinson Disease
University of Colorado, DenverN/AD (28)
ER-176
Parkinson Disease
Mayo ClinicD (28)
GLUCOSE, ANHYDROUS
Parkinson Disease
University Hospital Schleswig-HolsteinN/AD (28)
LECANEMAB
Parkinson Disease
Yonsei UniversityN/AD (28)
LIDOCAINE
Parkinson Disease
Babujinaya CelaN/AD (28)
LIPOPOLYSACCHARIDE
Parkinson Disease
University of ExeterD (28)
Pembrolizumab
Parkinson Disease
University of Colorado, DenverN/AD (28)
ROPIVACAINE
Parkinson Disease
Changhai HospitalN/AD (28)
Saffron
Parkinson Disease
Jinnah Postgraduate Medical CentreN/AD (28)
Sl-Apo
Parkinson Disease
Bial - Portela C S.A.D (28)
TZ-3321
Parkinson Disease
Washington University School of MedicineD (28)
Showing 126 to 150 of 153 assets
PreviousPage 6 of 7Next